Maligant Solid Tumor

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Maligant Solid Tumor trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Not Yet RecruitingEarly Phase 1

NCT07459283

The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors

This study is a prospective, single-arm, open-label, dose-escalation study. A total of 4 dose groups were pre-defined in this study. The drug was administered o…

China10 participantsStarted 2026-04

Treatment: INN805